PRL and sexual dysfunction: This drug increased PRL levels, yet some reports have shown that the switch from risperidone or paliperidone ER to paliperidone palmitate treatment (PP, an intramuscular depot formulation) reduced PRL concentration (316, 317) as well as sexual dysfunction (316), a common PRL-RAE.